Hormonal prevention of prostate cancer
- 1 January 2003
- journal article
- review article
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 21 (1) , 67-72
- https://doi.org/10.1016/s1078-1439(03)00004-8
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- The effect of finasteride in men with benign prostatic hyperplasiaJournal of Urology, 2002
- SELECT: the Selenium and Vitamin E Cancer Prevention Trial: rationale and designProstate Cancer and Prostatic Diseases, 2000
- Does long-term finasteride therapy affect the histologic features of benign prostatic tissue and prostate cancer on needle biopsy?Urology, 1999
- The pharmacokinetic modelling of GI198745 (dutasteride), a compound with parallel linear and nonlinear eliminationBritish Journal of Clinical Pharmacology, 1999
- Prospective Study of Sex Hormone Levels and Risk of Prostate CancerJNCI Journal of the National Cancer Institute, 1996
- Design of the Prostate Cancer Prevention Trial (PCPT)Controlled Clinical Trials, 1995
- Chemoprevention of Rat Prostate Carcinogenesis by Use of Finasteride or CasodexJNCI Journal of the National Cancer Institute, 1995
- Molecular genetics of steroid 5 alpha-reductase 2 deficiency.Journal of Clinical Investigation, 1992
- Geographic pathology of latent prostatic carcinomaInternational Journal of Cancer, 1982
- Latent carcinoma of prostate at autopsy in seven areas. Collaborative study organized by the International Agency for Research on Cancer, Lyons, FranceInternational Journal of Cancer, 1977